Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy C Toner

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Urology|October 12, 2011
Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009Andrew J Stephenson, Armen G Aprikian, Timothy D Gilligan, et al.
Oncogene|February 27, 2004
Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitorAlyssa M Morimoto, Nguyen Tan, Kristina West, et al.
American Journal of Clinical Oncology|April 14, 2009
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancerCarmel Pezaro, Mark A Rosenthal, Howard Gurney, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 8, 2022
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-upCiara Conduit, Thuan Tzen Koh, Michael S Hofman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 24, 2019
The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancerHayley S Whitford, Pawel Kalinowski, Adrian Schembri, et al.
EJNMMI Research|June 12, 2012
Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignanciesAndrew M Scott, Paul L Mitchell, Graeme O'Keefe, et al.
British Journal of Haematology|August 4, 2004
Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cellsH Miles Prince, Paul J Simmons, Genevieve Whitty, et al.
International Journal of Cancer|April 25, 2009
Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthoodKenneth K Khamly, Vicky J Thursfield, Michael Fay, et al.
British Journal of Clinical Pharmacology|January 4, 2026
The utility of genomics and functional imaging to predict sunitinib pharmacokinetics and pharmacodynamics: The predict SU studyMichael Michael, Guy C Toner, Vinod Ganju, et al.
Journal of Cancer Survivorship : Research and Practice|July 17, 2015
The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship studyAllan Ben Smith, Phyllis Butow, Ian Olver, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Urology|October 12, 2011
Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009Andrew J Stephenson, Armen G Aprikian, Timothy D Gilligan, et al.
Oncogene|February 27, 2004
Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitorAlyssa M Morimoto, Nguyen Tan, Kristina West, et al.
American Journal of Clinical Oncology|April 14, 2009
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancerCarmel Pezaro, Mark A Rosenthal, Howard Gurney, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 8, 2022
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-upCiara Conduit, Thuan Tzen Koh, Michael S Hofman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 24, 2019
The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancerHayley S Whitford, Pawel Kalinowski, Adrian Schembri, et al.
EJNMMI Research|June 12, 2012
Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignanciesAndrew M Scott, Paul L Mitchell, Graeme O'Keefe, et al.
British Journal of Haematology|August 4, 2004
Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cellsH Miles Prince, Paul J Simmons, Genevieve Whitty, et al.
International Journal of Cancer|April 25, 2009
Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthoodKenneth K Khamly, Vicky J Thursfield, Michael Fay, et al.
British Journal of Clinical Pharmacology|January 4, 2026
The utility of genomics and functional imaging to predict sunitinib pharmacokinetics and pharmacodynamics: The predict SU studyMichael Michael, Guy C Toner, Vinod Ganju, et al.
Journal of Cancer Survivorship : Research and Practice|July 17, 2015
The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship studyAllan Ben Smith, Phyllis Butow, Ian Olver, et al.
Pageof 3